Efficacy of Fentanyl Transdermal Patch in Impacted Mandibular Third Molar Surgery-A Comparative Study.

Analgesia Fentanyl Opioid analgesic Pain Third molar surgery

Journal

Journal of maxillofacial and oral surgery
ISSN: 0972-8279
Titre abrégé: J Maxillofac Oral Surg
Pays: India
ID NLM: 101538309

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 19 02 2021
accepted: 06 11 2022
pmc-release: 01 09 2024
medline: 3 8 2023
pubmed: 3 8 2023
entrez: 3 8 2023
Statut: ppublish

Résumé

Removal of mandibular third molars surgically is one of the most frequently performed oral surgical procedures which are often accompanied with post-operative pain, swelling and trismus. Despite general progress in pain management, moderate to severe acute post-operative pain after removal of lower third molars remains a problem. Fentanyl is an extremely effective drug in the treatment of severe chronic pain such as cancer pain and post-operative pains which acts by increasing patient's tolerance to pain. Fentanyl Transdermal System (FTS) is a rectangular transdermal patch which contains high concentration of fentanyl, a potent short-acting Schedule II opiate. In this study the efficacy of transdermal fentanyl for management of post-operative pain after impacted mandibular 3rd molar surgery is evaluated. 20 patients within the age group of 18-40 years with asymptomatic impacted mandibular third molars were equally divided into 2 groups as group A & group B which underwent surgery in Local Anaesthesia. In every patient one side belonged to group A and other side belonged to group B. 50 μg FTS was applied in group A while placebo patch was applied in group B. Patients in group A performed significantly better than group B in terms of mean pain intensity scores assessed by VAS and VRS along with minimum need of post-operative rescue analgesics. It was found that FTS resulted in significantly better pain relief, longer pain-free intervals, and lesser post-operative analgesic consumption.

Identifiants

pubmed: 37534350
doi: 10.1007/s12663-022-01820-4
pii: 1820
pmc: PMC10390443
doi:

Types de publication

Journal Article

Langues

eng

Pagination

609-613

Informations de copyright

© The Association of Oral and Maxillofacial Surgeons of India 2022. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Références

Am J Health Syst Pharm. 2005 Jun 1;62(11):1171-6
pubmed: 15914877
Med Oral Patol Oral Cir Bucal. 2016 Sep 01;21(5):e621-5
pubmed: 27475691
JAMA. 2004 Mar 17;291(11):1333-41
pubmed: 15026400
J Oral Maxillofac Surg. 1998 Apr;56(4):447-53; discussion 453-4
pubmed: 9541344
Clin Ther. 2008 Mar;30(3):469-81
pubmed: 18405786

Auteurs

Deepak Thakur (D)

Department of Oral and Maxillofacial Surgery, Rungta College of Dental Sciences and Research, Bhilai, India.

Shashikant Ravupalli (S)

Department of Oral and Maxillofacial Surgery, Rungta College of Dental Sciences and Research, Bhilai, India.

Sruthi Rao (S)

Department of Oral and Maxillofacial Surgery, Rungta College of Dental Sciences and Research, Bhilai, India.
V Y Institute of Medical Sciences, VY Hospital, Raipur, India.

Viplove Ukey (V)

Department of Oral and Maxillofacial Surgery, Rungta College of Dental Sciences and Research, Bhilai, India.

Manish Pandit (M)

Department of Oral and Maxillofacial Surgery, Rungta College of Dental Sciences and Research, Bhilai, India.

Aafreen Aftab (A)

Department of Oral and Maxillofacial Surgery, Rungta College of Dental Sciences and Research, Bhilai, India.

Classifications MeSH